Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Thrombolysis for Minor Stroke (ALLOW)
NCT06115070Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Mar 2025
- Primary completion
- Dec 2027
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06115070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06115070.